Carla Campbell

R&D Scientist I at Abzyme Therapeutics

Carla Campbell began their work experience in 2018, starting with a role as a Molecular Biology Intern at Rockland Immunochemicals, Inc. Carla worked in this position from June to August of that year. Following this, Carla joined Abzyme Therapeutics as an R&D Scientist I in October 2018, and currently continues to work in this role.

Carla Campbell obtained an Associate's degree in Biotechnology from Montgomery County Community College, which they pursued from 2016 to 2018. Subsequently, they enrolled at West Chester University of Pennsylvania, where they pursued a Bachelor of Science (BS) degree in Biology, General. Their studies at West Chester University commenced in 2020 and are expected to conclude in 2023.

Location

Royersford, United States

Links


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Abzyme Therapeutics

Abzyme Therapeutics is a biopharmaceutical company focused on developing modular single domain VHH antibody fragments for immunotherapy using proprietary antibody generation platforms.


Industries

Employees

11-50

Links